Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 1
2006 1
2007 1
2008 7
2009 2
2010 17
2011 22
2012 24
2013 32
2014 23
2015 22
2016 19
2017 25
2018 21
2019 19
2020 20
2021 18
2022 14
2023 21
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean sun yung chi (1 results)?
Antimicrobial activity of ceftazidime-avibactam against KPC-2-producing Enterobacterales: a cross-combination and dose-escalation titration study with relebactam and vaborbactam.
Kang MS, Baek JY, Ko J-H, Cho SY, Lee KY, Lee YH, Yang J, Kim TY, Huh HJ, Lee NY, Huh K, Kang C-I, Chung DR, Peck KR. Kang MS, et al. Among authors: cho sy. Microbiol Spectr. 2024 Apr 30:e0034424. doi: 10.1128/spectrum.00344-24. Online ahead of print. Microbiol Spectr. 2024. PMID: 38687076 Free article.
False-positive Aspergillus galactomannan immunoassay in the glucose component of total parenteral nutrition products.
Chong E, Ko J-H, Kim DR, Lee YH, Yang J, Kim H, Huh K, Kang C-I, Chung DR, Peck KR, Jeong IH, Kim TY, Huh HJ, Lee NY, Shin A, Kim Y-J, Sohn YM, Cho SY, Kang E-S. Chong E, et al. Among authors: cho sy. Microbiol Spectr. 2023 Dec 12;11(6):e0167323. doi: 10.1128/spectrum.01673-23. Epub 2023 Oct 6. Microbiol Spectr. 2023. PMID: 37800931 Free PMC article.
Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023.
Yang J, Hyeon S, Baek JY, Kang MS, Lee KY, Lee YH, Huh K, Cho SY, Kang CI, Chung DR, Peck KR, Won G, Lee HW, Kim K, Hwang I, Lee SY, Kim BC, Lee YK, Ko JH. Yang J, et al. Among authors: cho sy. J Korean Med Sci. 2023 Jul 10;38(27):e205. doi: 10.3346/jkms.2023.38.e205. J Korean Med Sci. 2023. PMID: 37431539 Free PMC article.
269 results